CVS vs FDMT · P/E 16, rev $402.07B vs rev $37.0K
CVS Health Corp (CVS) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CVS and FDMT stock pages for the full models.
Not investment advice.